✦ LIBER ✦
Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide®) in controlled ovarian stimulation for assisted reproduction
✍ Scribed by M. Ludwig; R. E. Felberbaum; P. Devroey; C. Albano; H. Riethmüller-Winzen; A. Schüler; W. Engel; K. Diedrich
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 39 KB
- Volume
- 264
- Category
- Article
- ISSN
- 0003-9128
No coin nor oath required. For personal study only.